In light of 2NE1 member Park Bom's long-awaited solo comeback taking place later on March 13 at 6 PM KST, the artist's new label D-Nation revisited her past illegal medication controversy, in order to clarify any misleading rumors. 

D-Nation stated:

"Many still refer to the incident from back in 2010, where a medication named Adderall was delivered to Korea from the United States via international mail, as an incident of 'illegal drug smuggling'; however, Park Bom has never partaken any illegal drug whatsoever, and so we hope to clarify the truth. 

In the United States, Adderall is a prescription medication officially approved by the National Food and Drug Administration. In Korea, the medication is still classified as an 'illegal substance', and distribution of this medication is prohibited. [Park Bom] remains apologetic toward the fact that [she] did not realize the consequences of her actions at the time, thus causing controversy. Nonetheless, people do not call it 'doing illegal drugs' when domestic patients utilize various other medications which are also labeled as 'illegal substances' in Korean standards, but which are authorized for prescription for certain treatments. Park Bom was at the time also taking the medication for the purpose of treatment, and seeing as no illegal substance was found during her urine analysis, the police also wrapped up the investigation without charges after understanding the situation.

Park Bom still currently suffers from an illness known as ADHD (Attention-deficit/hyperactivity disorder), and she is constantly receiving treatment from a domestic hospital while taking a similar prescription medication authorized for use by Korean standards. She is striving to overcome her illness, and hopes to return as a solo artist with courage despite her difficult times. We are very careful in the wake of our artist's new start, but also deeply hope that you will all look over Park Bom with warm gazes." 

Make sure to check out Park Bom's comeback single album 'Spring', later on March 13 at 6 PM KST.